DH334, a β-carboline anti-cancer drug, Inhibits the CDK activity of budding yeast
Yan Li(Beijing Tongren Hospital), Shuyi Si(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Wei Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanchang Wang(Florida State University), Rihui Cao(Sun Yat-sen University), Qinghe Ma(Luye Pharma (China)), Xiuyong Dai(Luye Pharma (China)), Fengshan Liang(Yale University), Fusheng Yu(Luye Pharma (China))
Cited by 77
Related Papers
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
|International Journal of Molecular Sciences|2018|200